Fig. 2From: LASP2 suppresses colorectal cancer progression through JNK/p38 MAPK pathway meditated epithelial-mesenchymal transitionLASP2 was negatively associated with progression and poor survival in CRC. Kaplan-Meier survival analysis in patients with CRC. a Overall survival of all patients. (n = 89, log rank = 5.490, P = 0.019). b Overall survival of patients in T3 and T4 stage (n = 80, log rank = 4.384, P = 0.036)Back to article page